loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Pilocarpine HCl

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Pilocarpine HCl

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,895Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orasis gains FDA approval for presbyopia eye drops
    Orasis gains FDA approval for presbyopia eye drops

    19 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-fda-approval-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-for-the-treatment-of-presbyopia-301959581.html

    PR NEWSWIRE
    19 Oct 2023
    Share Share
    AbbVie culls a second-gen presbyopia eye drop
    AbbVie culls a second-gen presbyopia eye drop

    27 Jun 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/after-cutting-back-on-vuity-last-fall-abbvie-culls-a-second-gen-presbyopia-eye-drop/

    Kyle LaHucik ENDPTS
    27 Jun 2023
    Share Share
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    07 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Pilocarpine Hydrochloride Ophthalmic Solution
    FDA Confirms Paragraph IV Patent Litigation for Pilocarpine Hydrochloride Ophthalmic Solution

    23 Feb 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-pilocarpine-hydrochloride-ophthalmic-solution-38318.pdf

    FDA
    23 Feb 2023
    Share Share
    Arctic Vision Begins Enrollment in PIII Trial of ARVN003 for Presbyopia
    Arctic Vision Begins Enrollment in PIII Trial of ARVN003 for Presbyopia

    04 Jul 2022

    // ASIAONE

    https://www.asiaone.com/business/arctic-vision-announces-first-patient-enrolled-phase-iii-clinical-trial-arvn003-presbyopia

    ASIAONE
    04 Jul 2022
    Share Share
    Allergan Shows Positive Topline Phase 3 Results of VUITY 1.25% in Presbyopia
    Allergan Shows Positive Topline Phase 3 Results of VUITY 1.25% in Presbyopia

    05 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/allergan-an-abbvie-company-announces-positive-topline-phase-3-results-evaluating-investigational-twice-daily-administration-of-vuity-pilocarpine-hci-ophthalmic-solution-1-25-in-adults-with-age-related-blurry-near-vision-pre-301517329.html

    PRNEWSWIRE
    05 Apr 2022
    Share Share